In mouse tumor models, supplementing methionine can increase perforin expression in exhausted CD8+ T cells by approximately 30%, enhance IFN-γ secretion by about 50%, and increase tumor growth inhibition by about 25%, demonstrating promising therapeutic prospects (163–165). The gene discussed is IFNG; the disease is neoplasm.